D.A. Davidson & Co’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,098
| Closed | -$593K | – | 1374 |
|
|
2023
Q4 | $593K | Sell |
3,098
-192
| -6% | -$36.8K | 0.01% | 888 |
|
|
2023
Q3 | $583K | Buy |
3,290
+57
| +2% | +$10.1K | 0.01% | 851 |
|
|
2023
Q2 | $614K | Buy |
3,233
+20
| +0.6% | +$3.8K | 0.01% | 860 |
|
|
2023
Q1 | $644K | Sell |
3,213
-36
| -1% | -$7.21K | 0.01% | 822 |
|
|
2022
Q4 | $772K | Buy |
3,249
+273
| +9% | +$64.9K | 0.01% | 706 |
|
|
2022
Q3 | $596K | Sell |
2,976
-1,105
| -27% | -$221K | 0.01% | 758 |
|
|
2022
Q2 | $595K | Buy |
4,081
+100
| +3% | +$14.6K | 0.01% | 766 |
|
|
2022
Q1 | $650K | Sell |
3,981
-248
| -6% | -$40.5K | 0.01% | 788 |
|
|
2021
Q4 | $717K | Buy |
4,229
+187
| +5% | +$31.7K | 0.01% | 755 |
|
|
2021
Q3 | $763K | Buy |
4,042
+171
| +4% | +$32.3K | 0.01% | 710 |
|
|
2021
Q2 | $656K | Buy |
3,871
+246
| +7% | +$41.7K | 0.01% | 752 |
|
|
2021
Q1 | $512K | Buy |
3,625
+763
| +27% | +$108K | 0.01% | 798 |
|
|
2020
Q4 | $372K | Buy |
2,862
+632
| +28% | +$82.1K | 0.01% | 792 |
|
|
2020
Q3 | $325K | Buy |
2,230
+221
| +11% | +$32.2K | 0.01% | 751 |
|
|
2020
Q2 | $298K | Buy |
2,009
+78
| +4% | +$11.6K | 0.01% | 752 |
|
|
2020
Q1 | $210K | Buy |
+1,931
| New | +$210K | ﹤0.01% | 854 |
|
|
2017
Q3 | – | Sell |
-150
| Closed | -$11K | – | 1106 |
|
|
2017
Q2 | $11K | Buy |
150
+10
| +7% | +$733 | ﹤0.01% | 2001 |
|
|
2017
Q1 | $7K | Hold |
140
| – | – | ﹤0.01% | 2103 |
|
|
2016
Q4 | $5K | Hold |
140
| – | – | ﹤0.01% | 2250 |
|
|
2016
Q3 | $9K | Buy |
140
+25
| +22% | +$1.61K | ﹤0.01% | 2063 |
|
|
2016
Q2 | $6K | Buy |
115
+47
| +69% | +$2.45K | ﹤0.01% | 2068 |
|
|
2016
Q1 | $4K | Buy |
68
+36
| +113% | +$2.12K | ﹤0.01% | 2070 |
|
|
2015
Q4 | $3K | Buy |
+32
| New | +$3K | ﹤0.01% | 2076 |
|